Clinical trial
TCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis
NCT00228228 · Sheba Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00228228 |
|---|---|
| Title | TCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis |
| Official title | T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis |
| Lead sponsor | Sheba Medical Center, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Biological |
| Interventions | T cell vaccination |
| Enrollment | 80 |
| Start date | May 1, 2002 |
| Completion | Dec 1, 2006 |
| First posted | Sep 28, 2005 |
| Last update posted | Aug 29, 2006 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: